Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17743 | 585 | 28.0 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
131 | 3 | HEMATOLOGY//HAEMOPHILIA//TRANSFUSION | 66936 |
966 | 2 | CLOPIDOGREL//PRASUGREL//TICAGRELOR | 10690 |
17743 | 1 | TICLOPIDINE//TICLOPIDINE HYDROCHLORIDE//E5510 | 585 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TICLOPIDINE | authKW | 2000840 | 20% | 33% | 116 |
2 | TICLOPIDINE HYDROCHLORIDE | authKW | 232504 | 1% | 64% | 7 |
3 | E5510 | authKW | 208784 | 1% | 100% | 4 |
4 | CLOPIDOGREL HYPERSENSITIVITY | authKW | 104392 | 0% | 100% | 2 |
5 | TICLOPIDINE HCL | authKW | 104392 | 0% | 100% | 2 |
6 | TICLOPIDINE INDUCED CHOLESTASIS | authKW | 104392 | 0% | 100% | 2 |
7 | CLOPIDOGREL CARBOXYLATE | authKW | 69593 | 0% | 67% | 2 |
8 | 1 1 CARBOXYLDIIMIDAZOLE | authKW | 52196 | 0% | 100% | 1 |
9 | 4 CYANO 5 4 METHOXYRING U C 14PHENYL 5 4 METHOXYPHENYL 4 PENTENOIC ACID | authKW | 52196 | 0% | 100% | 1 |
10 | ABNORMAL ALPHA LIPOPROTEIN | authKW | 52196 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 2705 | 20% | 0% | 119 |
2 | Hematology | 2320 | 20% | 0% | 115 |
3 | Pharmacology & Pharmacy | 1122 | 27% | 0% | 158 |
4 | Medicine, General & Internal | 665 | 17% | 0% | 98 |
5 | Cardiac & Cardiovascular System | 303 | 10% | 0% | 59 |
6 | Clinical Neurology | 196 | 9% | 0% | 55 |
7 | Medicine, Research & Experimental | 40 | 4% | 0% | 25 |
8 | Chemistry, Medicinal | 21 | 3% | 0% | 15 |
9 | Toxicology | 20 | 3% | 0% | 15 |
10 | Gastroenterology & Hepatology | 7 | 2% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ALLERGY ASTHMA FAMILY CLIN | 52196 | 0% | 100% | 1 |
2 | BARMHERZIGEN WESTERN HEILIGEN KREUZ | 52196 | 0% | 100% | 1 |
3 | BRONX VET ADM MED | 52196 | 0% | 100% | 1 |
4 | CARDIAC THORACIC VASC SURG | 52196 | 0% | 100% | 1 |
5 | CARDIOVASC CLIN PHARM | 52196 | 0% | 100% | 1 |
6 | HAEMOSTASIS THROMBOSIS ATHEROSCLEROSIS INFO | 52196 | 0% | 100% | 1 |
7 | HOSP MICROBIAL DIS | 52196 | 0% | 100% | 1 |
8 | HYPERTENS VASC MEDCARDIAC UNIT | 52196 | 0% | 100% | 1 |
9 | INTERNAL MED ALLERGY RHEUMATOL UNIT | 52196 | 0% | 100% | 1 |
10 | LOWER MANHATTAN PHARM | 52196 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL TRIALS AND META-ANALYSIS | 7453 | 0% | 7% | 2 |
2 | THROMBOSIS RESEARCH | 5192 | 5% | 0% | 32 |
3 | HAEMOSTASIS | 4207 | 2% | 1% | 10 |
4 | PLATELETS | 3698 | 2% | 1% | 11 |
5 | NOUVELLE REVUE FRANCAISE D HEMATOLOGIE | 3325 | 1% | 1% | 8 |
6 | CEREBROVASCULAR DISEASES | 2501 | 2% | 0% | 12 |
7 | ANNALS OF PHARMACOTHERAPY | 2463 | 3% | 0% | 16 |
8 | CLINICAL HEMORHEOLOGY | 1954 | 1% | 1% | 6 |
9 | THROMBOSIS AND HAEMOSTASIS | 1865 | 3% | 0% | 19 |
10 | JOURNAL OF DRUG DEVELOPMENT | 1241 | 0% | 2% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NOBLE, S , GOA, KL , (1996) DRUG EVALUATION - TICLOPIDINE - A REVIEW OF ITS PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY IN THE PREVENTION OF CEREBRAL ISCHAEMIA AND STROKE.DRUGS & AGING. VOL. 8. ISSUE 3. P. 214-232 | 60 | 83% | 30 |
2 | CALOGIURI, GF , AL-SOWAIDI, S , NETTIS, E , CORTELLINI, G , MACCHIA, L , VACCA, A , KOUNIS, NG , (2016) A JOINT ALLERGIST/CARDIOLOGIST CLASSIFICATION FOR THIENOPYRIDINES HYPERSENSITIVITY REACTIONS BASED ON THEIR SYMPTOMATIC PATTERNS AND ITS IMPACT ON THE MANAGEMENT STRATEGIES.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 222. ISSUE . P. 509 -514 | 41 | 66% | 0 |
3 | SYMEONIDIS, A , KOURAKLIS-SYMEONIDIS, A , SEIMENI, U , GALANI, A , GIANNAKOULAS, N , FRAGOPANAGOU, E , TINIAKOU, M , MATSOUKA, P , ZOUMBOS, N , (2002) TICLOPIDINE-INDUCED APLASTIC ANEMIA: TWO NEW CASE REPORTS, REVIEW, AND META-ANALYSIS OF 55 ADDITIONAL CASES.AMERICAN JOURNAL OF HEMATOLOGY. VOL. 71. ISSUE 1. P. 24-32 | 34 | 85% | 15 |
4 | SALTIEL, E , WARD, A , (1987) TICLOPIDINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN PLATELET-DEPENDENT DISEASE STATES.DRUGS. VOL. 34. ISSUE 2. P. 222-262 | 53 | 72% | 199 |
5 | MCTAVISH, D , FAULDS, D , GOA, KL , (1990) TICLOPIDINE - AN UPDATED REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN PLATELET-DEPENDENT DISORDERS.DRUGS. VOL. 40. ISSUE 2. P. 238-259 | 45 | 71% | 144 |
6 | GALLERANI, M , MANFREDINI, R , DONEGA, P , LANZA, F , DA BUSTI, M , VIGNA, GB , FELLIN, R , (2000) ADVERSE HAEMATOLOGICAL EFFECTS OF TICLOPIDINE - A REPORT OF FOUR CASES.CLINICAL DRUG INVESTIGATION. VOL. 19. ISSUE 3. P. 231 -237 | 32 | 78% | 0 |
7 | LEONE, N , GIORDANINO, C , BARONIO, MB , MORGANDO, A , DAVID, E , RIZZETTO, M , (2004) TICLOPIDINE-INDUCED CHOLESTATIC HEPATITIS SUCCESSFULLY TREATED WITH CORTICOSTEROIDS: A CASE REPORT.HEPATOLOGY RESEARCH. VOL. 28. ISSUE 2. P. 109-112 | 17 | 94% | 3 |
8 | PIZARRO, AE , ANDRADE, RJ , GARCIA-CORTES, M , LUCENA, MI , PEREZ-MORENO, JM , PUERTAS, M , SANCHEZ-MARTINEZ, H , MONTERO, JL , DURAN, JA , JIMENEZ, M , ET AL (2001) ACUTE HEPATITIS DUE TO TICLOPIDINE. A REPORT OF 12 CASES AND REVIEW OF THE LITERATURE.REVISTA DE NEUROLOGIA. VOL. 33. ISSUE 11. P. 1014 -1020 | 21 | 78% | 7 |
9 | PARADISO-HARDY, FL , ANGELO, CM , LANCTOT, KL , COHEN, EA , (2000) HEMATOLOGIC DYSCRASIA ASSOCIATED WITH TICLOPIDINE THERAPY: EVIDENCE FOR CAUSALITY.CANADIAN MEDICAL ASSOCIATION JOURNAL. VOL. 163. ISSUE 11. P. 1441-1448 | 29 | 56% | 14 |
10 | DESAGER, JP , (1994) CLINICAL PHARMACOKINETICS OF TICLOPIDINE.CLINICAL PHARMACOKINETICS. VOL. 26. ISSUE 5. P. 347-355 | 22 | 85% | 61 |
Classes with closest relation at Level 1 |